Skip to content

E76.02

Billable

Hurler-Scheie syndrome

HCC Category Mapping

V28HCC 49Lysosomal Storage Disorders
0.226
V24HCC 23Other Significant Endocrine and Metabolic Disorders
0.230
ESRDHCC 23Other Significant Endocrine and Metabolic Disorders
0.000
RxHCCHCC 41Lysosomal Storage Disorders
0.000

What This Code Means

An intermediate form of mucopolysaccharidosis type I with slower progression than Hurler's syndrome, causing progressive organ and skeletal damage with variable neurological involvement.

Coding Tips

  • Distinguish from Hurler's syndrome (E76.01) by documenting the intermediate clinical course and age of onset
  • Link to specific organ involvement such as cardiac, skeletal, or respiratory complications

Clinical Significance

Hurler-Scheie syndrome (MPS I-H/S) is an intermediate phenotype of mucopolysaccharidosis type I, with onset typically between ages 3-8 years and survival into the teens or twenties. It causes significant morbidity through joint stiffness, cardiac valve disease, and hepatosplenomegaly but generally spares cognitive function, distinguishing it from Hurler syndrome.

Documentation Requirements

  • Specific documentation of Hurler-Scheie (MPS I-H/S) intermediate phenotype
  • Confirmatory enzyme assay or IDUA gene mutation analysis
  • Current organ system involvement: cardiac, musculoskeletal, hepatic, respiratory, ophthalmologic
  • Treatment plan including enzyme replacement therapy (laronidase/Aldurazyme) or surgical interventions
  • Cognitive function status to support intermediate (not severe) phenotype classification

Commonly Confused Codes

Code Hierarchy

Open E76.02 in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.